Literature DB >> 10570644

[Analysis of indications and results of surgical treatment for patients with pulmonary metastasis].

L Kołodziejski1, J Góralczyk, S Dyczek, K Duda, H Dymek, T Nabiałek.   

Abstract

Ninety-three patients with pulmonary metastases (PM) were operated on between 1983 and 1997. Surgical complications occurred in 8 (9%) of patients. Two (3%) of patients died in hospital, 7 were operated on again due to further PM. An average survival after lung metastasis surgery was 40 months, median 22 months. 44% and 35% of patients survived respectively 3 and 5 years. Thanks to lung metastasis surgery the overall survival was longer; an average overall survival was 87 months (median 58 months). 58% and 38% of patients survived respectively 5 and 10 years. Time between treatment of primary tumour (PT) and lung metastasis surgery (disease free interval DFI) was on average 4 years, median 41 months. The patients who showed DFI-longer than 2 years had tendency to live longer (p = 0.086). Patients with PM are recommended to be operated on, even if further PM occur.

Entities:  

Mesh:

Year:  1999        PMID: 10570644

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  3 in total

1.  Radio-photothermal therapy mediated by a single compartment nanoplatform depletes tumor initiating cells and reduces lung metastasis in the orthotopic 4T1 breast tumor model.

Authors:  Min Zhou; Jun Zhao; Mei Tian; Shaoli Song; Rui Zhang; Sanjay Gupta; Dongfeng Tan; Haifa Shen; Mauro Ferrari; Chun Li
Journal:  Nanoscale       Date:  2015-12-14       Impact factor: 7.790

2.  Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models.

Authors:  Abhik Bandyopadhyay; Long Wang; Joseph Agyin; Yuping Tang; Shu Lin; I-Tien Yeh; Keya De; Lu-Zhe Sun
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

3.  Blockade of Autocrine TGF-β Signaling Inhibits Stem Cell Phenotype, Survival, and Metastasis of Murine Breast Cancer Cells.

Authors:  Zhao Liu; Abhik Bandyopadhyay; Robert W Nichols; Long Wang; Andrew P Hinck; Shui Wang; Lu-Zhe Sun
Journal:  J Stem Cell Res Ther       Date:  2012-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.